The 12 closest competitors and alternatives to AIRNA Corp among drug discovery companies — ranked by similarity to what AIRNA Corp actually does, not by market-cap band.
Subscribe to see AIRNA Corp’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
AIRNA Corp is a biotechnology company headquartered in Cambridge, Massachusetts, focused on developing RNA editing therapeutics. Its leading program utilizes ADAR-recruiting technology to target specific RNA locations for therapeutic applications.
AIRNA Corp is a drug discovery company headquartered in United States. It has raised at least $245M across the 4 funding rounds on record. Its most recent funding round, Series B, raised $155M in April 2025. Xcout tracks 15 named people at AIRNA Corp, including Kris Elverum (President and Chief Executive Officer). Xcout recorded 2 job postings from AIRNA Corp in the last 90 days.
9 more named people on record for AIRNA Corp, with roles, board committees and tenure — see the full roster →
At least $245M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $155M | 7 named | |
| Series B | $60M | 7 named | |
| Series B | $30M | 7 named | |
| SEC Form D filing | $1,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 2 job postings from AIRNA Corp in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see AIRNA Corp's hiring signals →
Ranked by semantic similarity — how close each company is to AIRNA Corp by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
Orbital Therapeutics is a biotechnology company developing RNA medicines, with a focus on engineered circular RNA and delivery technologies. Its programs are intended to address diseases that may benefit from durable, programmable protein expression, serving patients and healthcare providers through potential therapeutic products.
Similar drug discovery company
Eurus Therapeutics is a biotechnology startup headquartered in Fujisawa, Kanagawa Prefecture, Japan. Founded in 2021, the company is building an advanced drug-discovery platform based on a novel genome-editing technology called Eurus Editor.
Similar drug discovery company
Cassidy Bio is an AI-first biotechnology company founded in 2024 and based in Israel that is developing a programmable platform for gene editing. The company utilizes a genomic foundation model powered by artificial intelligence to design safer and more scalable gene editing therapies across various guides, editors, and delivery contexts.
Similar drug discovery company
Immitra Bio GmbH is a biotechnology startup and ETH Zürich spin-off developing a scalable in-vivo genetic medicine platform to treat rare genetic diseases. Headquartered in Schlieren, Switzerland, the company secured early-stage venture funding to advance its gene-editing therapies.
Similar drug discovery company
Vima Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts. The firm pioneers treatments for dystonia and related movement disorders, focusing on novel oral therapies. It develops specialized therapeutics designed to help patients regain mobility and freedom of movement.
Similar drug discovery company
Versameb AG is a privately held biopharmaceutical company focused on discovering and developing innovative RNA-based therapeutics.
Similar drug discovery company
Caldera Therapeutics, Inc. is a Cambridge, Massachusetts-based clinical-stage biotechnology company focused on treatments such as a bispecific inflammatory bowel disease (IBD) asset.
Similar drug discovery company
Astria Therapeutics, Inc. is a public biopharmaceutical company headquartered in Boston, Massachusetts, dedicated to developing life-changing therapies for patients.
Similar drug discovery company
Courage Therapeutics, Inc. is a for-profit biotechnology company founded in 2019 and headquartered in Newton, Massachusetts. The company operates in the biotech sector with a focus on developing therapeutic solutions.
Biopharmaceuticals
Arrakis Therapeutics, Inc. is a biopharmaceutical company located in Waltham, Massachusetts. The company focuses on discovering and developing small-molecule medicines that target RNA to address various serious diseases.
Biopharmaceutical
Aviceda Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts, focused on glyco-immune checkpoint therapeutics. The company develops novel, immune-mediated therapies designed to treat inflammatory and blinding diseases. Their proprietary technology platform leverages glycobiology to modulate the immune system for patient benefit.
Biopharmaceutical
Lerna Biopharma, formerly known as Cargene Therapeutics, is a preclinical-stage biopharmaceutical company founded in 2020. The company develops innovative RNA and oligonucleotide therapeutics, including siRNA, utilizing proprietary nucleic acid technologies and delivery platforms to address liver diseases and promote tissue regeneration.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for AIRNA Corpand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →